EYE vs PNV

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

EYE

NOVA EYE FPO [EYE]

55MEDIUM

PNV

POLYNOVO FPO [PNV]

56MEDIUM

Score Breakdown

EYE PNV
Technical
38
50
Catalyst
50
53
Sentiment
50
50
Fundamental
63
87
Momentum
60
46
Risk Gate
45
35

Key Metrics

EYE Metric PNV
$37.0MMarket Cap$618.3M
335KAvg Volume (20d)2.2M
N/AShort Interest+14.1%
$0.20552-Week High$1.715
$0.08652-Week Low$0.865
-3.8%Daily Change-0.6%
$0.125Entry Price$0.890
-42.4%ROE+12.5%
-21.3%Profit Margin+7.1%

Active Signals

EYE Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 3.8% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Low P/S ratio (1.1x)
●Strong revenue growth (+29%)
●EPS estimates revised upward (+10pts)

PNV Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Sitting near support — this level has held before and could attract buyers again
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.4x)
●Moderate revenue growth (+18%)
●Piotroski F-Score strong (8/9, low-confidence approx)

Ask Scout AI to compare EYE and PNV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
EYE Full Analysis → PNV Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).